$MLTX insider trading

Over the last 12 months, MoonLake Immunotherapeutics insiders reported no purchases and 9 sales totaling $9.3M across SEC Form 4 filings. 100% of the activity was filed under pre-arranged 10b5-1 trading plans.

$9.3M
9
3
100%
Side
$10K$100K$1.0M$10MJun '26JulAug
Reich Kristian
Bodenstedt Matthias
Santos da Silva Jorge

All insider trades

Jul 27, 2026Reich Kristian▼ Sale1,100$20$22K
Jul 22, 2026Reich Kristian▼ Sale52,448$20.02$1.0M-1.9%
Jul 20, 2026Reich Kristian▼ Sale43,700$20.09$878K-1.6%
Jul 15, 2026Reich Kristian▼ Sale16,105$20.01$322K-0.6%
Jul 10, 2026Santos da Silva Jorge▼ Sale102,225$20.02$2.0M-3.6%
Jul 1, 2026Santos da Silva Jorge▼ Sale47,775$20.03$957K-1.6%
Jun 22, 2026Bodenstedt Matthias▼ Sale39,120$22.04$862K-3.4%
Jun 18, 2026Bodenstedt Matthias▼ Sale17,876$19.67$352K-1.5%
Jun 17, 2026Reich Kristian▼ Sale150,000$19.01$2.9M-5%

Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $MLTX feed.

MLTX Insider Trading — Form 4 Buys & Sells | alphai